Cardiac Biomarkers Market Grows with CVD Burden and Rapid Diagnostic Advancements | Abbott Laboratories, Beckman Coulter, Roche Diagnostics Corporation, Becton Dickinson and Co.

Cardiac Biomarkers Market is expected to grow at a CAGR of 10.5% during the forecast period (2024-2031), according to DataM Intelligence report.

Cardiac Biomarkers Market Report by DataM Intelligence offers a detailed assessment of the global pharmaceutical and healthcare landscape, highlighting market size, key players, and critical growth drivers. With rising cardiovascular disease burden, advances in point-of-care testing, and increasing utilization of troponins, BNP, and CK-MB, the report delivers strategic insights for stakeholders in cardiac diagnostics and emergency care from 2025 to 2033.

Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cardiac-biomarkers-market?ophp

Cardiac biomarkers are proteins released into the bloodstream during heart stress or damage, aiding in the diagnosis and monitoring of cardiovascular diseases, especially myocardial infarction (heart attack). Key markers include troponin, CK-MB, and BNP. The market is expanding due to rising cardiovascular disease prevalence, demand for rapid diagnostic tools, and technological innovation in point-of-care testing.

Cardiac Biomarkers Market Competitors Overview:

Abbott Laboratories, Beckman Coulter, Roche Diagnostics Corporation, Becton Dickinson and Co., Bio-Rad Laboratories, BioMerieux, Siemens Healthcare, LumiraDx, Randox laboratories, and Thermo Fisher Scientific.

Important Industry Updates of 2023, 2024 and 2025:

✅ 2024 - FDA cleared Polymedco's PATHFAST hs‐cTnI-II assay for point-of-care cardiac troponin testing delivering ~17-min results-enabling rapid emergency department workflows.

✅ Q1 2025- FDA granted the first 510(k) clearance for an Lp(a) assay in molar units (Roche's Tina-quant®, for ASCVD risk stratification)

Methodology and Scope

The Cardiac Biomarkers Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cardiac-biomarkers-market?ophp

Cardiac Biomarkers Market Segments Overview:

∎ By Cardiac Biomarker Tests (Troponin, Creatine kinase, Myoglobin, Galectin-3, Other Biomarker Tests)
∎ By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Angina, others)
∎ By Testing Location (Laboratory Testing, Point of Care Testing)

The troponin segment dominates due to its critical role in diagnosing myocardial infarction and its widespread use in emergency settings for acute coronary syndrome evaluation.

Regional Overview for Cardiac Biomarkers Market:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

North America holds the highest share of the cardiac biomarkers market, fueled by high cardiovascular disease prevalence and early diagnostic adoption. Asia Pacific is the fastest growing region, with rising heart disease burden, growing awareness, and improved diagnostic infrastructure.

Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/customize/cardiac-biomarkers-market?ophp?ophp

The Report Covers:

➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.

People Also Ask:

➤ What are the current global trends in sales, production, imports, and exports within the Cardiac Biomarkers market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Cardiac Biomarkers market?

Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.